DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Hussain M, Mateo J, Fizazi K. et al.
Phase II study of olaparib versus enzalutamide or abiraterone for mCRPC with homologous recombination repair (HRR) gene alterations.
Ann Oncol 2019;
30: LBA12
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.